<DOC>
	<DOCNO>NCT02866929</DOCNO>
	<brief_summary>Numerous treatment protocol gear towards accelerate orthodontic treatment emerge past year appeal alternative patient practitioner . In context thin biotype , approach pose burden could precipitate periodontal detrimental change . Therefore , case selection implementation periodontal biotype enhance strategy become relevant consideration ensure long-term successful treatment outcomes . This study focus biological clinical value use porcine naturally cross-linked collagen matrix know Mucograft® . Within scope Surgically Accelerated Orthodontic Treatment ( SAOT ) structural material feature Mucograft® provide : 1 ) A protective effect thin biotype upon rapid orthodontic protusive/proinclination movement 2 ) Mucograft® enhance therapeutic window effect support increase tooth movement rate . The design randomize controlled clinical trial include cohort 40 subject distribute follow group I ) Ortho tx , II ) Ortho tx + Decortication , III ) Ortho tx + Decortication + Mucograft® , IV ) Ortho tx + Mucograft® . Comparing clinical , tomographic digital impression derive measurement capture clinical phenotype ; biologic phenotype derive evaluate crevicular fluid level tooth movement mediator Interleukin 1-β Interleukin-1RA . The significance innovative value proposal stem use Mucograft® ideal collagen-based biotype enhancer perform along corticotomy . This approach could prove effective increase therapeutic window allow accelerate orthodontic treatment , time , could decrease recession risk movement proclination antero-inferior incisor . Besides , use collagen scaffold alone could potentially trigger comparable orthodontic acceleratory outcome could evaluate alternative decortication .</brief_summary>
	<brief_title>A Biotype Enhancing Strategy For The Patient Undergoing Accelerated Orthodontics</brief_title>
	<detailed_description />
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<mesh_term>Malocclusion</mesh_term>
	<mesh_term>Malocclusion , Angle Class I</mesh_term>
	<criteria>Angle 's class I malocclusion Little 's grade II III dental crowd Periodontally stable patient Patients 2 mm keratinize gingiva least two site anteroinferior region Patient presence marginal tissue recession inferior incisor Patients metabolic neoplastic alteration History orthopedic surgery last 6 month History fracture last 6 month History bisphosphonates use Patient systemic compromise</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>orthodontics</keyword>
	<keyword>periodontics</keyword>
	<keyword>piezosurgery</keyword>
	<keyword>accelerate orthodontics</keyword>
	<keyword>Surgically Accelerated Orthodontic Treatment</keyword>
</DOC>